116 related articles for article (PubMed ID: 15212703)
1. Combined-modality therapy of rectal cancer with oxaliplatin-based regimens.
Minsky BD
Clin Colorectal Cancer; 2004 Jun; 4 Suppl 1():S29-36. PubMed ID: 15212703
[TBL] [Abstract][Full Text] [Related]
2. Combined-modality therapy of rectal cancer with irinotecan-based regimens.
Minsky BD
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):49-55. PubMed ID: 15685836
[TBL] [Abstract][Full Text] [Related]
3. Combined modality therapy of resectable rectal cancer: current approaches.
Minsky BD
Tech Coloproctol; 2004 Aug; 8(2):67-76. PubMed ID: 15309641
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin-based combined-modality therapy for rectal cancer.
Minsky BD
Semin Oncol; 2003 Aug; 30(4 Suppl 15):26-33. PubMed ID: 14523792
[TBL] [Abstract][Full Text] [Related]
5. Rectal cancer: integrating oxaliplatin into chemoradiation studies.
Ryan DP
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):38-41. PubMed ID: 11204662
[TBL] [Abstract][Full Text] [Related]
6. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.
Allegra CJ; Yothers G; O'Connell MJ; Beart RW; Wozniak TF; Pitot HC; Shields AF; Landry JC; Ryan DP; Arora A; Evans LS; Bahary N; Soori G; Eakle JF; Robertson JM; Moore DF; Mullane MR; Marchello BT; Ward PJ; Sharif S; Roh MS; Wolmark N
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26374429
[TBL] [Abstract][Full Text] [Related]
8. [Oxaliplatin and preoperative chemoradiotherapy in rectal cancer].
Ortholan C; Francois E; Follana P; Gérard JP
Bull Cancer; 2006 Feb; 93 Suppl 1():S51-8. PubMed ID: 16483946
[TBL] [Abstract][Full Text] [Related]
9. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
10. Integration of novel agents into combined-modality treatment for rectal cancer patients.
Rödel C; Sauer R
Strahlenther Onkol; 2007 May; 183(5):227-35. PubMed ID: 17497093
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
12. Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.
Rödel C; Arnold D; Hipp M; Liersch T; Dellas K; Iesalnieks I; Hermann RM; Lordick F; Hinke A; Hohenberger W; Sauer R
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1081-6. PubMed ID: 17881150
[TBL] [Abstract][Full Text] [Related]
13. Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?
Fakih MG
Ann Oncol; 2006 Jun; 17(6):1029-30; author reply 1030-1. PubMed ID: 16384877
[No Abstract] [Full Text] [Related]
14. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.
Gambacorta MA; Valentini V; Coco C; Morganti AG; Smaniotto D; Miccichè F; Mantini G; Barbaro B; Garcia-Vargas JE; Magistrelli P; Picciocchi A; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):139-48. PubMed ID: 15337549
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.
Glynne-Jones R; Meadows H; Wood W
Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):327-9. PubMed ID: 17434299
[No Abstract] [Full Text] [Related]
17. Combined-modality therapy for rectal cancer using irinotecan.
Minsky BD
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):35-8. PubMed ID: 12109805
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.
Koike J; Funahashi K; Yoshimatsu K; Yokomizo H; Kan H; Yamada T; Ishida H; Ishibashi K; Saida Y; Enomoto T; Katsumata K; Hisada M; Hasegawa H; Koda K; Ochiai T; Sakamoto K; Shiokawa H; Ogawa S; Itabashi M; Kameoka S
Cancer Chemother Pharmacol; 2017 Mar; 79(3):519-525. PubMed ID: 28150022
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
Rödel C; Grabenbauer GG; Papadopoulos T; Hohenberger W; Schmoll HJ; Sauer R
J Clin Oncol; 2003 Aug; 21(16):3098-104. PubMed ID: 12915600
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
Rödel C; Liersch T; Hermann RM; Arnold D; Reese T; Hipp M; Fürst A; Schwella N; Bieker M; Hellmich G; Ewald H; Haier J; Lordick F; Flentje M; Sülberg H; Hohenberger W; Sauer R
J Clin Oncol; 2007 Jan; 25(1):110-7. PubMed ID: 17194912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]